News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Whistleblower Lawsuit Costs Genzyme Corporation (GENZ) $22 Million


1/6/2014 7:48:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sanofi subsidiary Genzyme agrees to pay $22.3 million to settle accusations that its sales rep encouraged off-label use of the Seprafilm surgical product. Massachusetts-based Genzyme Corp., a subsidiary of Sanofi (NYSE:SNY), agreed to pay $22.3 million to settle a whistleblower lawsuit accusing the company of off-label marketing of its Seprafilm surgical product. Seprafilm protects organs and muscles following surgery, forming a barrier that prevents them from attaching to one another during healing.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES